TABLE 2.
Controlled release of antimicrobial agents on the PEEK-PDA (2 mg/ml dopamine hydrochloride) surface.
| Ion | Sample | Method | Bacterial strain | Antibacterial test | Antibacterial property | Mechanism | Biological effect | Reference |
|---|---|---|---|---|---|---|---|---|
| AgNPs | Tollens’ reagent (0.02 mol/L) [ammonia into AgNO3 solution (0.02 mol/L)] | PEEK-PDA immersed in the Tollens’ reagent for 30 min | E. coli , S. aureus, and S. aureus | Plate counting and SEM IAI model in rat femur | 97.9 ± 0.8% 99.8 ± 0.1% (antibacterial rate) S. aureus growth was significantly inhibited on the surface | Fast Ag+ release initially, then slow release for long-term | Showed low toxicity to MC3T3-E1 cell and possessed good biocompatibility and osseointegration | Gao et al. (2017) |
| AgNPs、SF/GS | AgNO3–gentamicin (500 lg/mL in PBS) and silk fibroin | SP–PDA–Ag immersed into gentamicin followed by three silk layers | E. coli and S. aureus | Plate counting and SEM | Greatly enhanced the antibacterial effects and antiadhesion ability | The release rate of Ag+ and GS increased with decreasing pH | PDA and silk fibroin can balance cytocompatibility and antibacterial ability | Yan et al. (2018) |
| KR-12 | KR-12 solution (1 mg/ml in 10 mM Tris–HCl buffer) | PEEK-PDA immersed in KR-12 solution under reverse nitrogen (N2) flow overnight | S. aureus and S. aureus | Plate counting and SEM IAI model in rat femur | Effectively inhibited bacteria proliferation and biofilm formation in vitro and in vivo | Release of KR-12 which has a broad spectrum of antibacterial activity | rBMSCs: improved adhesion, proliferation, and osteogenic differentiation; in vivo: promoted osteointegration in rat femur | Meng et al. (2020) |
| GS | PDA and GS diluted in Tris–HCl solution (2 mg/ml and 3 mg/ml) | SPEEK was immersed in the left solution for 12 h | E. coli , S. aureus, and S. aureus | Plate counting IAI model in rat femur | Continuous antibacterial abilities. Imaging showed no evidence of osteomyelitis | GS release | Possessed good biocompatibility and the immunoregulatory ability | Sun et al. (2021) |
| Mino liposomes | Minocycline (Mino), liposome, and dexamethasone (DEX) | PEEK-PDA immersed in the Dex/Mino liposome solution obtained by the thin-film hydration method | S. mutans, P. gingivalis, and S. mutans | Plate counting and microbial viability assay kit-WST subcutaneous infection model of rats | Improved the antibacterial activity and inhibited the initial adhesion. The antibacterial efficiency was about 97.4% | Liposomal Mino releasing and benign cell adhesion on the functionalized PEEK surface | In vitro, improved osteogenic differentiation of human mesenchymal stem cells. In vivo, enhanced osteointegration | Xiao Xu et al. (2019) |
| Zn2+–Mg2+ | Mg(NO3)2·6H2O、Zn(NO3)2·6H2O、2,5-dihydroxy-terephthalic acid (DHTA) dexamethasone (DEX) | PEEK-PDA was dipped in Zn−Mg-MOF74 composite obtained by hydrothermal synthesis and then coated by DEX | E. coli, S. aureus, and S. aureus | Plate counting and SEM fluorescence microscope subcutaneous infection model of rats | Significantly inhibited bacterial proliferation. Much smaller number of bacteria | Mg2+, Zn2+, and DHTA release. The alkaline microenvironment due to the coating degradation | Improved vascularization and osteogenic differentiation | Xiao et al. (2021) |
| Van-GNPs | vancomycin (Van)–Gelatin nanoparticles (GNPs) | Plasma modification (PDA/P-PEEK) combines two-step desolvation (Van-GNPs) | S. aureus and S. mutans | Plate counting and SEM | Inhibited bacteria adhesion and the cell membrane bursted on the Van-GNPs/PEEK surface | Vancomycin release | Good osteogenesis without cytotoxicity | Tianjie Chen et al. (2021) |
| AgNPs–µCuO/SF | Cu(NO3)2 •3H2O、AgNO3, Silk fibroin SPEEK | μCuO was prepared by hydrothermal solution followed by polymerization | E. coli and S. aureus | Plate counting and SEM | Effectively inhibited bacteria adhesion and biofilm formation | Cu2+ and Ag+ release | Showed better osteogenesis in the rabbit tibial defect model | Yan et al. (2020) |